A health official in this city said the recent rise in reported human immunodeficiency virus (HIV) cases is not ...

The other major complication of HTLV-1 is a rare type of cancer: adult T-cell leukemia/lymphoma (ATL). It’s estimated that ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

Scientists in Japan have discovered a genetic "silencer" within the HTLV-1 virus that helps it stay hidden in the body, evading the immune system for decades. This silencer element essentially turns ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV.

Global cuts to HIV research and support funding have the Joint United Nations Programme on HIV and AIDS (UNAIDS) worried ...

Until recently, the UN was on track to meet its target of ending AIDS as a public health threat by 2030. But with the U.S.